Recent studies have shown that C-terminal binding protein-1 and -2 (CtBP1/2) are overexpressed in ovarian cancer, and CtBP2 expression is correlated with poor prognosis8,9. This evidence concerns the gene CTBP1 and ovarian carcinoma.